{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320032785280.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jinorgbio.2012.06.013"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0162013412002115?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0162013412002115?httpAccept=text/plain"}}],"dc:title":[{"@value":"What do we know about the reduction of Pt(IV) pro-drugs?"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320032785280","@type":"Researcher","foaf:name":[{"@value":"Ezequiel Wexselblatt"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320032785281","@type":"Researcher","foaf:name":[{"@value":"Dan Gibson"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01620134"}],"prism:publicationName":[{"@value":"Journal of Inorganic Biochemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-12","prism:volume":"117","prism:startingPage":"220","prism:endingPage":"229"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0162013412002115?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0162013412002115?httpAccept=text/plain"}],"createdAt":"2012-07-02","modifiedAt":"2022-01-20","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004234289324800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Polymeric micelles for targeted tumor therapy of platinum anticancer drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367085358720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual-action Pt(Ⅳ) prodrugs and targeted delivery in metal-organic frameworks : overcoming cisplatin resistance and improving anticancer activity"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jinorgbio.2012.06.013"},{"@type":"CROSSREF","@value":"10.1080/17425247.2017.1307338_references_DOI_EUxr7x7eDbO3YMLI5DDVPoUuSSR"},{"@type":"CROSSREF","@value":"10.1246/bcsj.20220218_references_DOI_EUxr7x7eDbO3YMLI5DDVPoUuSSR"}]}